نتائج البحث - Gargano, M
- يعرض 1 - 3 نتائج من 3
-
1
-
2
Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volun... حسب Halstenson, C. E., Shamp, T., Gargano, M. A., Walsh, R. M., Patchen, M. L.
منشور في 2016نص -
3
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherap... حسب Thomas, M., Sadjadian, P., Kollmeier, J., Lowe, J., Mattson, P., Trout, J. R., Gargano, M., Patchen, M. L., Walsh, R., Beliveau, M., Marier, J. F., Bose, N., Gorden, K., Schneller, F.
منشور في 2017نص